Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Eilt: Großinvestoren vor Einstieg in diesen Biotech Hot Stock - Massives Kaufsignal. Neuer 133% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73280/AC_Vidac_170124.001.png
Eilt: Großinvestoren vor Einstieg in diesen Biotech Hot Stock - Massives Kaufsignal. Neuer 133% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Großinvestoren vor Einstieg in diesen Biotech Hot Stock - Massives Kaufsignal. 133% Biotech Aktientip nach 15.973%

 

17.01.24 08:02

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

Eilt: Großinvestoren vor Einstieg in diesen Biotech Hot Stock - Massives Kaufsignal. Neuer 133% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73280/AC_Vidac_170124.001.png
Eilt: Großinvestoren vor Einstieg in diesen Biotech Hot Stock - Massives Kaufsignal. Neuer 133% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Großinvestoren vor Einstieg in diesen Biotech Hot Stock - Massives Kaufsignal. 133% Biotech Aktientip nach 15.973%

 

17.01.24 08:02

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

Time to buy these 3 healthcare companies that raised revenue guidance?: https://www.marketbeat.com/logos/articles/med_20240114165541_chart-exas2.jpg
Time to buy these 3 healthcare companies that raised revenue guidance?

The new year brings a clean slate heading into the fourth-quarter earnings season. Companies can usually gauge if their previous forecasts were in line or need to be adjusted to warn or prepare

Time to buy these 3 healthcare companies that raised revenue guidance?: https://www.marketbeat.com/logos/articles/med_20240114165541_chart-exas2.jpg
Time to buy these 3 healthcare companies that raised revenue guidance?

The new year brings a clean slate heading into the fourth-quarter earnings season. Companies can usually gauge if their previous forecasts were in line or need to be adjusted to warn or prepare

Affirm's pullback, short squeeze potential present a second chance: https://www.marketbeat.com/logos/articles/med_20240115101316_affirms-pullback-short-squeeze-potential-present-a.jpg
Affirm's pullback, short squeeze potential present a second chance

Buy now, pay later (BNPL) leader Affirm Holdings Inc. (NASDAQ: AFRM) is having a 20% off sale that may be one of the best bargains in retail.

After riding a nine-week win streak to $52.48 on

3 high-yielding, small banks to buy on the dip: https://www.marketbeat.com/logos/articles/med_20240115092448_chart-cade-1152023ver001.png
3 high-yielding, small banks to buy on the dip

Results from the big banks have the financial sector on the cusp of a correction. The news isn't bad, but strengths were priced into the market, setting it up for a healthy and needed reset. The

Surgery Partners feeling no pinch from macroeconomic weakness: https://www.marketbeat.com/logos/articles/med_20240114164939_chart-sgry.jpg
Surgery Partners feeling no pinch from macroeconomic weakness

Surgery Partners Inc. (NASDAQ: SGRY) is a leading healthcare services provider that owns and operates over 180 outpatient surgical centers in 31 states. Its integrated delivery model includes

PayPal gearing up for a breakout despite shifting sentiment: https://www.marketbeat.com/logos/articles/med_20240115120327_paypal-gearing-up-for-a-breakout-despite-shifting.jpg
PayPal gearing up for a breakout despite shifting sentiment

Few names outperformed PayPal Holdings Inc. (NASDAQ: PYPL) during the COVID-19 pandemic. Imagine a company that not only weathered the storm of the COVID-19 pandemic but thrived amidst the chaos,

Bitcoin ETFs: A two-day ranking of top performers: https://www.marketbeat.com/logos/articles/med_20240115114740_bitcoin-etfs-a-two-day-ranking-of-top-performers.jpg
Bitcoin ETFs: A two-day ranking of top performers

The recent approval and launch of eleven Bitcoin spot ETFs have added a thrilling chapter. Building up to the much-anticipated approval, the market was brimming with anticipation. 

As the U.S.

2 biotechs with promising weight-loss drugs coming: https://www.marketbeat.com/logos/articles/med_20240114165130_chart-vktx2.jpg
2 biotechs with promising weight-loss drugs coming

Clinical weight-loss medications have been making headlines. GLP-1 drugs like Novo Nordisk A/S (NYSE: NVO) owned Ozempic and Wegovy and Eli Lilly and Co. (NYSE: LLY) owned Mounjaro and Zepbound

Power Plays: MSFT, NVDA, GOOGL, META dominate market moves: https://www.marketbeat.com/logos/articles/med_20240115072106_power-plays-msft-nvda-googl-meta-dominate-market-m.jpg
Power Plays: MSFT, NVDA, GOOGL, META dominate market moves

Last week, an interesting picture of triumph was painted in the stock market, with the technology sector taking the lead. Now, this may come as no surprise. The stars of the show were none other

Affordable networking stocks to watch on the Juniper buyout: https://www.marketbeat.com/logos/articles/med_20240114163634_chart-infn.jpg
Affordable networking stocks to watch on the Juniper buyout

Hewlett Packard Enterprise Co. (NYSE: HPE) will acquire network communications equipment provider Juniper Networks Inc. (NASDAQ: JNPR) for around $14 billion or $40 per share. It sent shockwaves

Power Plays: MSFT, NVDA, GOOGL, META dominate market moves: https://www.marketbeat.com/logos/articles/med_20240115072106_power-plays-msft-nvda-googl-meta-dominate-market-m.jpg
Power Plays: MSFT, NVDA, GOOGL, META dominate market moves

Last week, an interesting picture of triumph was painted in the stock market, with the technology sector taking the lead. Now, this may come as no surprise. The stars of the show were none other

Power Plays: MSFT, NVDA, GOOGL, META dominate market moves: https://www.marketbeat.com/logos/articles/med_20240115072106_power-plays-msft-nvda-googl-meta-dominate-market-m.jpg
Power Plays: MSFT, NVDA, GOOGL, META dominate market moves

Last week, an interesting picture of triumph was painted in the stock market, with the technology sector taking the lead. Now, this may come as no surprise. The stars of the show were none other

PayPal gearing up for a breakout despite shifting sentiment: https://www.marketbeat.com/logos/articles/med_20240115120327_paypal-gearing-up-for-a-breakout-despite-shifting.jpg
PayPal gearing up for a breakout despite shifting sentiment

Few names outperformed PayPal Holdings Inc. (NASDAQ: PYPL) during the COVID-19 pandemic. Imagine a company that not only weathered the storm of the COVID-19 pandemic but thrived amidst the chaos,

PayPal gearing up for a breakout despite shifting sentiment: https://www.marketbeat.com/logos/articles/med_20240115120327_paypal-gearing-up-for-a-breakout-despite-shifting.jpg
PayPal gearing up for a breakout despite shifting sentiment

Few names outperformed PayPal Holdings Inc. (NASDAQ: PYPL) during the COVID-19 pandemic. Imagine a company that not only weathered the storm of the COVID-19 pandemic but thrived amidst the chaos,

Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. Neuer 152% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73259/Aktiencheck160124.001.png
Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. Neuer 152% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. 152% Biotech Aktientip nach 134.452% mit Biogen

 

16.01.24

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. Neuer 152% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73259/Aktiencheck160124.001.png
Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. Neuer 152% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. 152% Biotech Aktientip nach 134.452% mit Biogen

 

16.01.24

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. Neuer 152% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73259/Aktiencheck160124.001.png
Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. Neuer 152% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. 152% Biotech Aktientip nach 134.452% mit Biogen

 

16.01.24

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

MarketBeat ‘Stock of the Week’: Lucid a high risk EV penny stock: https://www.marketbeat.com/logos/articles/med_20240115085652_marketbeat-stock-of-the-week-lucid-a-high-risk-ev.png
MarketBeat ‘Stock of the Week’: Lucid a high risk EV penny stock

Since making a second run into the $50’s two years ago, Lucid Group Inc. (NASDAQ: LCID) has been a ‘clear’ loser. 

On Friday, shares of the California-based luxury electric vehicle (EV) maker

Lululemon stock falls on raised guidance: https://www.marketbeat.com/logos/articles/med_20240114163833_chart-lulu2.jpg
Lululemon stock falls on raised guidance

Premium athleisure brand Lululemon Athletica Inc.  (NASDAQ: LULU) entered the holiday shopping season with solid momentum, sending shares through its all-time highs and peaking at $516.39 on Dec

Lululemon stock falls on raised guidance: https://www.marketbeat.com/logos/articles/med_20240114163833_chart-lulu2.jpg
Lululemon stock falls on raised guidance

Premium athleisure brand Lululemon Athletica Inc.  (NASDAQ: LULU) entered the holiday shopping season with solid momentum, sending shares through its all-time highs and peaking at $516.39 on Dec

3 retailers to compound your wealth this cycle: https://www.marketbeat.com/logos/articles/med_20240115071736_3-retailers-to-compound-your-wealth-this-cycle.jpg
3 retailers to compound your wealth this cycle

Today's market is the epitome of opportunity for those who know where to look. Considering that most market analysts suggest the stock market is overvalued today, by measures such as the Buffett

Insidertrades.com uncovers the hottest insider activity from 2023: https://www.marketbeat.com/logos/articles/med_20240115074451_chart-wmt-1152024ver001.png
Insidertrades.com uncovers the hottest insider activity from 2023

Insider activity can be a telling indicator of where a stock is heading, and the activity was hot in 2023. This is a look at the hottest insider trades tracked by Insidertrades.com. Within it are

Insidertrades.com uncovers the hottest insider activity from 2023: https://www.marketbeat.com/logos/articles/med_20240115074451_chart-wmt-1152024ver001.png
Insidertrades.com uncovers the hottest insider activity from 2023

Insider activity can be a telling indicator of where a stock is heading, and the activity was hot in 2023. This is a look at the hottest insider trades tracked by Insidertrades.com. Within it are